Second edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
Better treatments... Better lives.
The Australasian Leukaemia & Lymphoma Group (ALLG) is Australia and New Zealand’s only not-for-profit blood cancer clinical trial research group.
Driven by our purpose ‘Better treatments…Better lives’, the ALLG is committed to improving the treatment, lives and survival rates of patients with blood cancers through clinical trial conduct. Working collaboratively with blood cancer specialists locally and internationally, our impact is profound.
Important ALLG Downloads
ALLG has had a positive financial year. This success is due to our strong partnerships and collaborations. In particular, we thank our members and patients and look forward to more trials creating better treatments and better lives.
Our membership includes more than 700 blood cancer specialists who are united by a common goal to find better ways to treat blood cancers through clinical trial conduct.
Help make a difference to the life of someone who has blood cancer. For patients and their loved ones, your donation means an improved chance of cure and better quality of life.
Gain access to cutting-edge, potentially life-saving new treatments before they’re widely available to the public. Many people with cancer are now living longer, with a better quality of life, due to clinical trials.
Memberships
Donations
Clinical Trials & Research
Australasian Leukaemia and Lymphoma Group is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity.